文献速递儿童口腔牙体牙髓病

乳磨牙不可逆性牙髓炎症状行全冠髓切断术的前瞻性单臂预试验

Pulpotomy for treating primary molars with clinical symptoms indicative of irreversible pulpitis: A prospective single-arm pilot study.
PubMed 文献 · J Dent · 2025-09-28

术后24小时和7天VAS疼痛评分显著下降,6个月临床和影像学成功率分别为100%和93.9%。结论提示MTA牙髓切断术是此类患牙可行的治疗选择。

要点

  • 有不可逆性牙髓炎症状但术中牙髓有活力的乳磨牙可考虑全冠髓切断术。
  • 2%次氯酸钠棉球压迫止血联合MTA和预成金属冠修复是标准化方案。
  • 6个月临床成功率100%、影像学成功率93.9%,术后疼痛显著缓解。

核心结论

  • MTA全冠髓切断术对临床诊断为不可逆性牙髓炎的有活力乳磨牙可提供疼痛缓解,6个月临床和影像学结局良好。

主要发现

  • 组内分析显示术后24小时和7天VAS疼痛评分较术前显著降低。
  • 术后6个月临床成功率为100%,影像学成功率为93.9%。
  • 年龄、性别、牙位、龋坏部位、止血时间和根分叉透射影与治疗结局无显著关联。

关键数值与推荐

  • 止血采用2%次氯酸钠湿润的无菌棉球在根髓断面上适度压迫最多6分钟。
  • 放置2-3 mm厚MTA作为牙髓切断药物,并以预成金属冠修复。
  • 疼痛评估采用经验证的五点视觉模拟量表(VAS)。

临床怎么用

  • 对临床有不可逆性牙髓炎症状但术中确认牙髓有活力的乳磨牙,可考虑全冠髓切断术作为替代治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Assess the treatment outcomes and pain relief afforded by full pulpotomy in vital primary molars with clinical symptoms indicative of irreversible pulpitis. METHODOLOGY: This study was designed as a multi-centre, single-arm, prospective clinical trial registered under ClinicalTrials.gov (NCT06149845). Fifty carious primary molars with clinical symptoms indicative of irreversible pulpitis and pulp intra-operatively assessed to be vital, underwent full coronal pulpotomy following a standardized procedural protocol. Haemostasis was achieved by moderately compressing a 2 % NaOCl-moistened sterile cotton pellet over the radicular pulp stumps for up to 6-minutes. A 2-3 mm layer of mineral trioxide aggregate (MTA) was placed as the pulpotomy medicament and the tooth restored with a pre-formed metal crown. Pre- and post-operative pain scores were evaluated using a validated five-point visual analogue scale (VAS). Clinical and radiographic outcomes were assessed after 6-months. Treatment outcome effects of potential prognostic factors like age, gender, tooth type, site of caries, haemostasis time, and furcal radiolucency were also analysed. RESULTS: Intra-group analysis of VAS pain scores revealed significant pain reduction 24-h and 7-d after the pulpotomy treatment procedure. The 6-month post-treatment clinical and radiographic success rates of the pulpotomised primary molars were 100 % and 93.9 %, respectively. No significant association was evident between treatment outcomes and the investigated variables. CONCLUSIONS: The pain relief afforded and the 6-month clinical and radiographic outcomes indicate that MTA pulpotomy is a successful treatment option for vital primary molars clinically diagnosed with irreversible pulpitis. CLINICAL SIGNIFICANCE: This study strengthens the currently available evidence for pulpotomy to be considered as an alternate treatment modality for cariously exposed vital primary molars presenting with symptomatic irreversible pulpitis.

来源:J Dent,查看原文。版权归原作者所有。

引用

  1. Philip N, Kowash M, Bani-Hani T, et al. Pulpotomy for treating primary molars with clinical symptoms indicative of irreversible pulpitis: A prospective single-arm pilot study. J Dent. 2025. PMID: 41027503. doi:10.1016/j.jdent.2025.106140

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。